Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

Priority Meds vs Walgreens Weight Management

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

7.1

Priority Meds

Best for pending product verification
★★★3.6

Starting at $113/mo

CompoundedSemaglutideTirzepatideFlat-Dose Pricing
Visit Priority Meds
7.1

Walgreens Weight Management

Best for mainstream telehealth GLP-1 access
★★★3.6
SemaglutideTirzepatide
Visit Walgreens Weight Management

Side-by-Side Comparison

FeaturePriority MedsWalgreens Weight Management
Overall Score7.1/107.1/10
Starting Price$113/mo
Editorial Rating3.6 ★ /53.6 ★ /5
Features4 features2 features
States Available050
Compounded✓ Yes
Brand Name
FSA/HSA Accepted
FDA WarningsNoneNone

Pros & Cons

Priority Meds

Pros

  • Flat-dose pricing (no dose-escalation increases) per competitor sources
  • B-vitamin co-compounding (sema+B12, tirz+B6) is a differentiator in the segment
  • Clearwater FL based US operation

Cons

  • Stub entry — exact drug formulary, pricing tiers, states served, and pharmacy partners need a YMYL verification pass
  • Confidence is LOW until that pass is done

Walgreens Weight Management

Pros

  • Both semaglutide and tirzepatide available

Cons

  • Pricing not publicly disclosed

Our Verdict

Both Priority Meds and Walgreens Weight Management score equally well overall — the right choice depends on your priorities. Choose Priority Meds if you want pending product verification, or Walgreens Weight Management if mainstream telehealth GLP-1 access matters most to you.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.